Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
26 May 2014
GLP-1 receptor agonists are licensed in the UK for type 2 diabetes mellitus and specific weight management indications, not for cognitive impairment or dementia GLP-1 receptors are present in brain regions involved in memory and learning, prompting research into potential neuroprotective effects Ongoing clinical trials, including studies of semaglutide in Alzheimer's disease, are examining whether these medications benefit cognitive function Common adverse effects include gastrointestinal symptoms
K., Eurich, D
However, as with any supplement, if you have pre-existing medical conditions, are pregnant or breastfeeding, or are taking other medications, we always recommend consulting with your healthcare professional before incorporating any new supplement into your regimen
US$ 24.33
US$ 24.10
US$ 25.30
